Quanta Pharma Retatrutide 30mg + Free BW

Quanta Pharma Retatrutide 30mg + Free BW
Quanta Pharma

Quanta Pharma Retatrutide 30mg + Free BW

Retatrutide · Lyophilized Powder Vial · 30mg
In Stock 现货 -9%
£160.00
In stock - ships from UK warehouse
🚚 UK domestic delivery - cold chain / light-protected packaging
前往购买 / 询价

In short 产品简述

Quanta Pharma Retatrutide 30mg is a triple agonist peptide that activates GLP-1, GIP, and glucagon receptors. It enhances insulin secretion, increases energy expenditure, and reduces appetite, resulting in significant improvements in weight loss and metabolic regulation.

Specifications 规格参数

含量规格 Content 30mg
剂型 Format 冻干粉瓶
总容量 Total volume 3ml
活性成分 Ingredient Retatrutide
CAS 号 2381089-83-2

About the Product 产品详情

Why not try our SerenQ Retatrutide Pens?

Pre-mixed and ready to use – no reconstitution needed 🔥 Currently on sale!

20mg – £140

40mg – £210

Included Free

+ 3ml Bacteriostatic Water with order

Quanta Pharma Retatrutide 30mg

is a pharmaceutical-grade

triple agonist peptide

targeting GLP-1, GIP, and glucagon receptors simultaneously. This lyophilised vial from

Quanta Pharma

offers researchers a high-purity compound for advanced metabolic and weight management studies. The 30mg dosage provides an ideal starting point for research protocols. Available for

UK delivery

with fast dispatch.

Quanta Pharma Retatrutide 30mg Specifications

Peptide

Retatrutide

Type

Triple Agonist

Dosage

30mg/vial

Form

Lyophilised

Half-Life

~6 Days

Storage

2-8°C

Retatrutide 30mg

Quanta Pharma

Quanta Pharma Retatrutide Research Benefits

Triple receptor action

Superior weight management

Enhanced fat oxidation

Glycemic control

Extended half-life

How Quanta Pharma Retatrutide Works

Quanta Pharma Retatrutide

is a

triple agonist peptide

that simultaneously activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the Glucagon receptor. This unique triple-action approach sets it apart from all other incretin-based peptides.

The GLP-1 and GIP receptor activation enhances insulin secretion, reduces appetite, and slows gastric emptying. The addition of Glucagon receptor agonism is what makes

Quanta Pharma Retatrutide

truly unique, as it directly stimulates fat oxidation, increases energy expenditure, and promotes hepatic fat reduction. This three-pronged approach delivers superior metabolic effects in research settings.

Quanta Pharma Retatrutide vs Tirzepatide vs Semaglutide

Semaglutide

targets only the GLP-1 receptor.

Tirzepatide

activates both GLP-1 and GIP receptors.

Quanta Pharma Retatrutide

goes further by targeting all three receptors: GLP-1, GIP, and Glucagon. Clinical research has demonstrated that this triple agonist approach produces the most significant weight reduction results of any incretin-based compound studied to date, making

Quanta Pharma Retatrutide

the most advanced option for metabolic research.

Why Choose Quanta Pharma Retatrutide 30mg?

Quanta Pharma

is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. The 30mg vial of

Quanta Pharma Retatrutide

provides an accessible entry point for research protocols, while maintaining the same quality standards as the larger 50mg variant. Each vial undergoes rigorous quality control to ensure consistency and reliability.

⚠️ FOR LABORATORY RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Safety Classification:

Legal Notice:

This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.

What's in the Box 包装清单

  • 1 x lyophilized powder vial (aluminum crimp cap + butyl stopper). Vial label carries batch number and expiry date.

Usage 使用说明

  • Reconstitute with sterile or bacteriostatic water per the research protocol. Swirl gently after reconstitution; avoid vigorous shaking. Disinfect the stopper before withdrawing a dose.

Handling & Storage 储存条件

  • Unreconstituted: refrigerate at 2-8 C, protect from light. Do not freeze; avoid repeated freeze-thaw cycles. Use within the supplier-stated period after reconstitution.

Applications 应用方向

Retatrutide 减重代谢 血糖控制

For research purposes only 免责声明

Information on this entry is compiled from the public sales page (The Ped Shop) and is for research and reference only. Listed products are shown for research use, not sold as drugs or dietary supplements, and are not intended to diagnose, treat, cure or prevent any disease. Actual specification, price and stock are subject to the supplier page.

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.